e.g. Tata motors, Reliance MF, 500570

Fredun Pharmaceuticals Ltd. - Research Center

539730 FREDUN Group (X) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 348.16 274.68 224.46 133.89 112.77
Expenses
Material consumed 261.32 208.69 177.11 102.25 80.81
Manufacturing expenses 14.06 9.58 7.15 4.77 5.29
Personnel expenses 12.50 11.53 10.66 8.66 8.95
Selling expenses 1.10 0.10 0.18 - 0.04
Adminstrative expenses 21.19 17.00 15.56 9.08 9.42
Expenses capitalised - - - - -
Cost of sales 310.17 246.90 210.66 124.75 104.50
Operating profit 37.98 27.78 13.80 9.14 8.27
Other recurring income 0.92 1.82 1.63 1.40 0.52
Adjusted PBDIT 38.90 29.60 15.43 10.54 8.79
Financial expenses 13.65 9.28 4.67 4.16 4.41
Depreciation 3.80 2.81 2.16 2.00 1.88
Other write offs - - - - -
Adjusted PBT 21.45 17.51 8.60 4.37 2.49
Tax charges 5.83 6.70 2.26 1.19 0.59
Adjusted PAT 15.62 10.81 6.34 3.18 1.90
Non recurring items -0.07 0.05 -0.02 -1.16 -
Other non cash adjustments - - - - -
Reported net profit 15.55 10.86 6.31 2.02 1.90
Earnigs before appropriation 44.10 28.86 18.24 12.19 9.75
Equity dividend 0.33 0.31 0.31 0.27 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 43.77 28.55 17.93 11.93 9.75
Close
Add Fredun Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Fredun Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback